USP <60>
The USP for Bcc
USP <60> took effect in 2019 for the testing of questionable microorganisms in non-sterile pharmaceutical products, specifically to address recent Burkholderia cepacia complex (Bcc) infections linked to non-sterile aqueous products. Hardy Diagnostics offers culture media for the cultivation and isolation of Bcc.